Kirsty Gallacher gave a health update on an ear tumor that led to her quitting a GB News job
Kirsty Gallacher has revealed she is having radiotherapy for a benign tumor in her ear.
This health update comes two years after Gallacher, 47, received the tumor diagnosis after having sudden hearing loss, which led to her developing tinnitus.
Speaking about the scheduled radiotherapy, Gallacher has said: “The tumor isn’t going to go until I have radiotherapy to shrink it and I’m not doing that at the moment, but I’m watching it.
“Radiotherapy is the last resort. I will do it in the summer, but it’s not

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the nineteen analysts that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $89.00. 

